International university collaboration to tackle Ross River virus

An international collaboration to discover and develop new therapeutic…


UniQuest and UCL Business team up on therapeutics collaborations

A new international collaboration is set to uncover ground-breaking…


Queensland initiative to find new drug treatments secures state funding

An initiative to create new and potentially life-changing drugs has taken a…


UniQuest licenses intellectual property to Organovo for kidney toxicity screening and drug development

BRISBANE, Australia and SAN DIEGO, October 15, 2015 — UniQuest, the main…


UniQuest congratulates Spinifex Pharmaceuticals and Professor Maree Smith on winning national awards

UniQuest congratulates Spinifex Pharmaceuticals and Professor Maree Smith on…


Innovative industry-UQ partnerships recognised

Four industry-research projects on drug development, business innovation,…


Medicare subsidy for ImpediMed's early lymphedema detection technology

More cancer patients will now have access to early lymphedema detection…


Protagonist raises US$18m Series B finance to take IBD treatment into the clinic

In 2014, Protagonist Therapeutics, Inc. closed its US$18 Million Series B…


A message from Professor Peter Høj: UQ’s Vice-Chancellor and President

Research translation is a passion of mine, and commercialisation is…